Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesNo recent work listed

Ke Sheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6696-5409; OpenAlex author ID A5056932023; NIH RePORTER profile ID 9233546. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
1
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 grant · 2020: 1 paper

Papers 2

  1. Quantifying vascular invasion in pancreatic cancer-a contrast CT based method for surgical resectability evaluation. Co-author DOI 10.1088/1361-6560/ab8106↗
  2. Dosimetric comparison of 6 MV and 15 MV single arc rapidarc to helical TomoTherapy for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.meddos.2010.07.002↗

Grants 1

  1. Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy R01CA188300↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wensha Yang · 2 shared papers, 2011–2020 · strength 0.14
  2. Zhaoyang Fan · 1 shared paper, 2020 · strength 0.11
  3. Yi Lao · 1 shared paper, 2020 · strength 0.11
  4. John David · 1 shared paper, 2020 · strength 0.11
  5. Richard Tuli · 1 shared paper, 2020 · strength 0.11
  6. Jinbo Yue · 1 shared paper, 2011 · strength 0.03
  7. Jing Cai · 1 shared paper, 2011 · strength 0.03
  8. Stanley Benedict · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.